hotspot -WSS

hotspot

author：leisure time 2025-09-30 22:28:39 - browse：99

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Antibiotic resistance and the global rise in human conflict

WSS

Leon Gautier, last member of French D

Chronically ill young patients struggle to find fertility info

Some in Scotland's Orkney Islands want to return to Norway after 550 years

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

Federal weight loss drug coverage is 30 years out of date

Feng Zhang, Grail founder join forces on new gene editing startup

hotspot

hotspot

explore

BioMarin wins approval for gene therapy to treat hemophilia A

GSK Flovent asthma inhalers replaced by authorized generics

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NASA releases new images of 'fingerprint

Peter Hotez and the public health issue of online harassment

Chronically ill young patients struggle to find fertility info

Hepatitis C has a cure — but many Americans still lack access to it

Antibiotic resistance and the global rise in human conflict

knowledge

Federal weight loss drug coverage is 30 years out of date

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

A single drug, study failures leave Anavex with nothing but cash

3 medical device trends to watch in 2024

Morgan Health, with ambitious aims, wants you to know it’s still here

JPM: CVS says Medicare Advantage patients are impacting profits

explore

leisure time

leisure time

hotspot